This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
For the second quarter in a row, Waters reported year over year revenue growth of 17 percent, which company officials attributed to increased sales for its Acquity UPLC systems and columns and the continuation of a few positive trends.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.